Paediatric Strategy Forums

Upcoming Forum

16th ACCELERATE

Paediatric Strategy Forum

B7-H3

Autumn 2026

Europe

More details will come soon!


:
:
:
Days
Hours
Minutes
Seconds

About the Forums


Paediatric Strategy Forums are multi-stakeholder meetings in which strategies regarding new drug development are discussed. Each Forum focuses on either a given paediatric malignancy or the development of a class of compounds with regards to their mechanism of action. These scientific meetings are aimed at facilitating prioritisation in order to better meet the needs of patients and to increase feasibility of paediatric developments.
Suggest new topics
question mark icon
What?
 

A multi-stakeholder Forum where all Stakeholders share information and discuss the strategy of new drug development with regards to their Mechanism of Action (MoA) to address unmet medical needs in a transparent scientific discussion

calendar icon
When?
 

Q1/ Midst/ Q4 every year

location icon
Where?
 

2 live Paediatric Strategy Forums – 1 in Europe & 1 in US

 



rocket icon
Why?
 

To share information, to facilitate the development of innovative medicines and ultimately their introduction into the standard-of-care of children with malignancies

Agreement by all involved (industry and academia) based on scientific arguments

Which product, based on current evidence, is considered to have the highest potential to address unmet medical needs 

The sequence in which other available (or emerging) products should be developed or deferred. So that  as soon as a development is completed (either due to futility or efficacy) others are already prepared for evaluation

Engage regulatory agencies in a consolidated effort early in development

Monitoring changes in regulatory submissions and approvals both in Europe and the US (changing from adult-condition based waivers to scientifically and medically relevant waivers)

Publish results publicly via summaries and manuscripts

Past Forums

15th Paediatric Strategy Forum
15th Paediatric Strategy Forum
ON Antibody Drug Conjugates

10 - 11 June 2025, Denver



Agenda: HERE

14th Paediatric Strategy Forum ON Novel ways to target and enhance efficiency of anti-GD2 therapies
14th Paediatric Strategy Forum
ON Novel ways to target and enhance efficiency of anti-GD2 therapies

24 - 25 October 2024, Amsterdam



Summary: HERE

13th Paediatric Strategy Forum

13th Paediatric Strategy Forum

for diffuse midline gliomas

8 - 9 May 2024, Toronto


Summary: HERE

Scientific Manuscript: HERE

12TH Paediatric Strategy Forum for CDK4/6, CDK 7 and CDK 9 Inhibitors
12TH Paediatric Strategy Forum
for CDK4/6, CDK 7 and CDK 9 Inhibitors

26-27 October 2023, Amsterdam


Summary: HERE

Scientific Manuscript: HERE

11TH Paediatric Strategy Forum for PI3K, mTOR and AKT inhibitors
11TH Paediatric Strategy Forum
for PI3K, mTOR and AKT inhibitors

3-4 April 2023, Boston



Summary: HERE

Scientific Manuscript: HERE

10TH Paediatric Strategy Forum for DNA Damage Pathway Inhibitors

10TH Paediatric Strategy Forum

for DNA Damage Pathway Inhibitors

27-28 October 2022, Amsterdam



Scientific manuscript: HERE

9TH PAEDIATRIC STRATEGY FORUM FOR MEDICINAL PRODUCT DEVELOPMENT IN MAPK PATHWAY INHIBITORS
19TH PAEDIATRIC STRATEGY FORUM
FOR MEDICINAL PRODUCT DEVELOPMENT IN MAPK PATHWAY INHIBITORS

28 March & 29 March 2022, Virtual



Scientific manuscript: HERE

8TH PAEDIATRIC STRATEGY FORUM FOR MEDICINAL PRODUCT DEVELOPMENT OF MULTI-TARGETED KINASE INHIBITORS IN BONE SARCOMA
8TH PAEDIATRIC STRATEGY FORUM
FOR MEDICINAL PRODUCT DEVELOPMENT OF MULTI-TARGETED KINASE INHIBITORS IN BONE SARCOMA

30 November & 1 December 2021, Virtual



Scientific manuscript: HERE

7TH PAEDIATRIC STRATEGY FORUM FOR MEDICINAL PRODUCT DEVELOPMENT OF CAR T-CELLS IN CHILDREN AND ADOLESCENTS

7TH PAEDIATRIC STRATEGY FORUM FOR MEDICINAL PRODUCT DEVELOPMENT OF CAR T-CELLS IN CHILDREN AND ADOLESCENTS

25-27 May 2021, Virtual



Scientific manuscript: HERE

6th Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies
6th Paediatric Strategy Forum
for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies

13-14 January 2021, Virtual



Scientific manuscript: HERE

5th Paediatric Strategy Forum for Medicinal Product Development of Epigenetic Modifiers in Children and Adolescents
5th Paediatric Strategy Forum for Medicinal Product Development of Epigenetic Modifiers in Children and Adolescents

30 November & 1 December 2021, Virtual



Scientific manuscript: HERE

4th Paediatric Strategy Forum for Medicinal Product Development for Acute Myeloid Leukaemia in Children and Adolescents
4th Paediatric Strategy Forum for Medicinal Product Development for Acute Myeloid Leukaemia in Children and Adolescents

11-12 April 2019, Rotterdam



Public summary: HERE

Scientific manuscript: HERE

3rd Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients
3rd Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients

5-6 September 2018, EMA, London



Public summary: HERE

Scientific manuscript: HERE

2nd Paediatric Strategy Forum for Medicinal product development for mature B-cell malignancies in children
2nd Paediatric Strategy Forum for Medicinal product development for mature B-cell malignancies in children

13-14 November 2017, EMA, London



Public summary: HERE

Scientific manuscript: HERE

1st Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies
1st Paediatric Strategy Forum
for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies

30-31 January 2017, EMA, London


Public summary: HERE